TIGIT and mantle cell lymphoma: Another CAR-T-cell therapy study revealed that decreased cytotoxic T cells, increased myeloid-derived suppressor cells, and TIGIT overexpression in tumor cells and T cells were associated with MCL relapse after CAR-T-cell therapy.36